mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to pegaspargase

Detalles Bibliográficos
Autores principales: Koo, Grace, Anvari, Sara, Friedman, Debra L., Zarnegar-Lumley, Sara, Szafron, Vibha, Kahwash, Basil M., Onasch, K. Michelle, Hall, Laura, Phillips, Elizabeth J., Stone, Cosby A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2022
Materias:
Clinical Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526431/
https://www.ncbi.nlm.nih.gov/pubmed/34678498
http://dx.doi.org/10.1016/j.jaip.2021.09.051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526431/
https://www.ncbi.nlm.nih.gov/pubmed/34678498
http://dx.doi.org/10.1016/j.jaip.2021.09.051

Ejemplares similares